加快的依赖于融合的内体逃生改善了递送的酶载荷的活性
Angel Luis Vázquez-Maldonado1, Teresia Chen2, Diego Rodriguez2
1Department of Chemistry, University of California, Berkeley, California 94720, United States.
ACS central science
|April 28, 2025
概括
一种新的迷你蛋白,AV5.3,通过提前实现内体逃逸,改善了治疗性蛋白质向细胞的输送. 这种增强的输送可以保持细胞质中的酶活性,成功地挽救细胞功能.
科学领域:
- 细胞生物学 细胞生物学
- 生物技术是生物技术.
- 蛋白质工程是一种蛋白质工程.
背景情况:
- 有效地将生物物质输送到哺乳动物细胞细胞醇对于治疗应用至关重要.
- 晚期内体的酸性环境可以降解内化蛋白质,降低其残留活性.
- ZF5.3是一种微型蛋白质,已知具有高效的内体体逃脱与蛋白质载荷.
研究的目的:
- 重新设计ZF5.3以实现更早的内体细胞逃逸.
- 评估早期逃逸对输送的酶活性的影响.
- 为了证明改进的输送系统的治疗潜力.
主要方法:
- 重新设计ZF5.3小蛋白的序列,以创建AV5.3.3.
- 评估AV5.3带有或没有酶载荷的内体逃脱效率和时间.
- 使用AV5.3和ZF5.3.3输送一种pH敏感酶 (DHFR).
- 在细胞质中测量酶活性,并在CHO细胞中拯救DHFR缺失.
主要成果:
- 在不影响效率的情况下,AV5.3比ZF5.3实现了更早的内体细胞逃逸.
- 与AV5.3的早期逃脱导致细胞质中pH敏感酶的酶活性显著增加.
- 输送AV5.3-DHFR成功地挽救了CHO细胞中的DHFR缺陷,证明了功能性蛋白质的输送.
结论:
- AV5.3是一种改进的微型蛋白质,用于增强生物质的细胞质输送.
- 较早的内体逃脱与治疗性蛋白质活性增加直接相关.
- AV5.3提供了一种有前途的战略,可以直接将活性治疗性蛋白质和酶输送到细胞中.
更多相关视频
相关概念视频
Carrier-Mediated Transport
212
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
212
ER Retrieval Pathway
3.6K
In the secretory pathway, vesicles transport proteins from one cellular compartment to another in forward transport to deliver the protein to its correct location. Occasionally, misfolded proteins and incorrect proteins escape their original compartments, and a retrieval pathway is used to return the escaped proteins to their original compartment.
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...
3.6K
Receptor-mediated Endocytosis
5.8K
Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
5.8K
The Early Endosome: Endocytosis of Transferrin
3.2K
Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
3.2K
Vesicular Trasport: Endocytosis, Transcytosis and Exocytosis
611
Vesicular transport is a cellular process that encompasses the engulfment of particles or dissolved substances by cells. It involves endocytosis, transcytosis, and exocytosis.
Endocytosis is a cellular mechanism that involves the inward folding of the cell membrane to create vesicles that capture and transport large drug molecules. This process comprises two distinct methods: pinocytosis (often referred to as "cell drinking") and phagocytosis (often referred to as "cell...
Endocytosis is a cellular mechanism that involves the inward folding of the cell membrane to create vesicles that capture and transport large drug molecules. This process comprises two distinct methods: pinocytosis (often referred to as "cell drinking") and phagocytosis (often referred to as "cell...
611
Recycling Endosomes and Transcytosis
2.5K
The recycling endosome, also known as the endosomal recycling compartment (ERC), is a part of the slow-recycling process of the endocytic pathway. Molecules internalized through receptor-mediated endocytosis are either degraded in the lysosomes or are recycled to the plasma membrane through the fast- or slow-recycling route.
The recycling endosome is not a single organelle but an extensively tubulated network of recycling pathways. It functions in storing molecules or transporting them across...
The recycling endosome is not a single organelle but an extensively tubulated network of recycling pathways. It functions in storing molecules or transporting them across...
2.5K


